Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial Cells at therapeutic concentrations-Reference-Cited by-同舟云学术

Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial Cells at therapeutic concentrations

Published:2009-06-15 Issue:9 Volume:69 Page:1017-1023
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Murtola Teemu J.,Pennanen Pasi,Syvälä Heimo,Bläuer Merja,Ylikomi Timo,Tammela Teuvo L.J.

Publisher

Wiley

Subject

Urology,Oncology

Reference33 articles.

1. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation;Yoo;Mol Pharmacol,2007

2. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression;Kim;J Biol Chem,2005

3. Aspirin inhibits highly invasive prostate cancer cells;Lloyd;Int J Oncol,2003

4. Statins and prostate cancer prevention: Where are we now and future directions;Murtola;Nat Clin Pract Urol,2008

5. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma;Chaffer;BMC Cancer,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer CellsviaInhibition of RAD51 Expression;Anticancer Research;2023-12-30

2. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients;Frontiers in Endocrinology;2023-07-25

3. PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal;Current Medicinal Chemistry;2023-06-07

4. Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting;International Journal of Molecular Sciences;2023-02-02

5. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer;International Journal of Molecular Sciences;2023-01-04